Moreover, as inflammatory cytokines (i.e., IL6, TNF-α) whose levels are elevated in MASLD inhibit ADAMTS13 secretion and activity, an increased number of vWF multimers becomes available and, together with the rise in FVIII, enhances the prothrombotic status [125,126]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.